|
|
 |
|
Viewing report
|
|
|
|
Boehringer Ingelheim Partnering Guide 2008
CurrentPartnering, July 2008, Pages: 51
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Bigpharma – The Top 50
Chapter 3 – Most active bigpharma dealmakers
3.1 Bigpharma M&A activity
3.2 Bigpharma partnering
Chapter 4 – Top bigpharma deals – 2000-7
4.1 Bigpharma M&A
4.2 Bigpharma partnering
Chapter 5 – Submitting Opportunities to Bigpharma such as Boehringer Ingelheim
5.1 How to submit an opportunity
5.2 Opportunity submission template
5.3 Sending emails
5.4 Face to face at partnering events
5.5 Online submission forms
Chapter 6 – Forthcoming bigpharma partnering events
6.1 Forthcoming events
Chapter 7 – Boehringer Ingelheim – therapy locator
7.1 How to use the therapy matrix tables
7.2 Therapeutic area definitions
7.3 Boehringer Ingelheim – Therapeutic target matrix – marketed and pipeline compounds
7.5 Boehringer Ingelheim – Therapeutic target matrix – expressed partnering interests
7.6 Boehringer Ingelheim – Therapeutic target matrix – recent deals – 2005-2007
Chapter 8 – Bigpharma Company Profiles
8.1 How to use company profiles
8.2 Field definitions
8.3 Boehringer Ingelheim company profile
Company contact details
Subsidiary companies
Primary therapy areas
Business development contacts
Company description
Marketed therapeutic indications
Pipeline (phase I-III) therapeutic indications
Partnering interests
Partnering interests - therapeutic indications
Partnering frequency per annum - 2000-2008
Current partner companies (2005-8)
Recent deals 2005-2008
- By deal type
- By stage of development
- By therapy area
Contract documents available online - link direct to each document
Figures in report
Figure 1: Bigpharma – top 50 by pharma revenues 2007
Figure 2: Leading Bigpharma M&A companies, 2005-7
Figure 3: Leading Bigpharma partnering companies, 2005-7
Figure 4: Leading M&A deals involving bigpharma by value, 2005-7
Figure 5: Leading partnering deals by value, 2005-7
Figure 6: Typical partnering opportunity submission template
Figure 7: Partnering events 2008-9
Figure 8: Therapeutic area definitions
Figure 9: Therapeutic target matrix – marketed and pipeline compounds
Figure 10: Therapeutic target matrix – expressed partnering interests
Figure 11: Therapeutic target matrix – recent deals 2005-7
Figure 12: Company profile template and definitions used in report
Figure 13: Boehringer Ingelheim – Dealmaking frequency 2000-2007
Figure 14: Boehringer Ingelheim – recent deals (2005-2008) by deal type
Figure 15: Boehringer Ingelheim – recent deals (2005 – 2008) by stage of development
Figure 16: Boehringer Ingelheim – recent deals (2005 – 2008) by therapy area
Figure 17: Recent Boehringer Ingelheim partnering deals (2003-2008) where contract document available
Figure 18: Online partnering resources
Customers who bought this item also bought
Boehringer Ingelheim GmbH Deals Briefing
Bigpharma Partnering Agreements
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
Pre-clinical Stage Partnering Agreements in Biopharma
Clinical Stage Partnering Agreements in Biopharma
Discovery Stage Partnering Agreements in Biopharma
Bigpharma Agreements Handbook 2007
Bigpharma Combined Handbook 2007
Option and Evaluation Agreements in Pharma and Biotech
Non-Hodgkin Lymphoma Drug Pipeline Report
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer
Distribution Agreements in Biopharma
|
|
|
|
